Ganoderma lucidum: Current advancements of characteristic components and experimental progress in anti-liver fibrosis.

Ganoderma lucidum

OncologyImmune supportMetabolic healthLiver support

SpeciesReishi, Lingzhi

JournalFrontiers in pharmacology

Year2022

Metadata-grounded summary

Article summary

Metadata-grounded summary: This review indexes research on Ganoderma lucidum in Frontiers in pharmacology in 2022. MycoData maps the paper to oncology, immune support, metabolic health, liver support based on its title, species context, article metadata, and study classification.

Citation

Peng H, Zhong L, Cheng L, Chen L, Tong R, Shi J, et al. (2022). Ganoderma lucidum: Current advancements of characteristic components and experimental progress in anti-liver fibrosis. Frontiers in pharmacology https://doi.org/10.3389/fphar.2022.1094405 PMID: 36703748

Open citation